This inventor holds 2 USPTO granted patents. Top assignees: Genovis Ab, Hansa Medical Ab. Active years: 2003-2008.
Company Filing History:
Years Active: 2003-2008
Title: Innovations of Anders Sjoholm
Introduction
Anders Sjoholm is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biotechnology, particularly in the study of proteins related to pathogenicity and virulence. With a total of 2 patents, his work has implications for both analytical procedures and vaccine development.
Latest Patents
Sjoholm's latest patents include the characterization of a protein known as Streptococcal inhibitor of complement-mediated lysis, referred to as protein SIC. This protein, derived from serotype M1, plays a crucial role in inhibiting hemolysis by interacting with plasma proteins such as clusterin and members of the cystatin protein superfamily, including histidine-rich glycoprotein (HRG). The protein comprises several partial amino acid sequences that contribute to its functionality. Additionally, the protein and its specific antibodies can be utilized in analytical procedures to detect virulence in samples and can also be incorporated into vaccine compositions.
Career Highlights
Throughout his career, Anders Sjoholm has worked with prominent companies in the biotechnology sector, including Genovis AB and Hansa Medical AB. His expertise in protein characterization has positioned him as a valuable contributor to advancements in medical research and applications.
Collaborations
One of his notable collaborators is Lars Björck, with whom he has worked on various projects related to his research.
Conclusion
Anders Sjoholm's innovative work in protein research and his contributions to biotechnology highlight the importance of scientific advancements in understanding and combating diseases. His patents and collaborations continue to influence the field positively.